on 15 Feb 2022
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
88609830 filed on 09th Sep 2019
Registration Number
6646899 registered on 15th Feb 2022
Correspondent Address
Bruce W. Longbottom
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
The mark consists of a circular design made up of four connected curved shapes in the colors pink and magenta with the top right side extended. The color white appearing as the interior of the mark is not claimed as a feature of the mark, and is merely intended to represent a transparent area in the mark. Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of canceRead More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer
08th May 2020
08th May 2020
Medical information services in the field of cancer
11th Aug 2020
11th Aug 2020
No 88609830
No Service Mark
No
No
No
No
No
No
No
No
No
26.01.27 -
Circles containing irregular exterior lining or elements not amounting to a decorative border
26.01.28 -
Miscellaneous circular designs with an irregular circumference
26.03.28 -
Miscellaneous designs with overall oval shape, including amoeba-like shapes and irregular ovals
The mark consists of a circular design made up of four connected curved shapes in the colors pink and magenta with the top right side extended. The color white appearing as the interior of the mark is not claimed as a feature of the mark, and is merely intended to represent a transparent area in the mark.
| Status Date | Action Taken |
|---|---|
| 15th Feb 2022 | REGISTERED-PRINCIPAL REGISTER |
| 11th Jan 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 10th Jan 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 06th Jan 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 28th Dec 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Dec 2021 | USE AMENDMENT FILED |
| 06th Dec 2021 | TEAS STATEMENT OF USE RECEIVED |
| 20th Jul 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Jul 2021 | EXTENSION 3 FILED |
| 16th Jul 2021 | EXTENSION 3 GRANTED |
